
JuneBrain Inc. develops telehealth Optical Coherence Tomography (OCT) devices and AI software to optimize the remote monitoring of neurological and retinal diseases. Their user-friendly, portable solutions aim to enhance research, streamline clinical trials, and broaden access to advanced care in clinical and point-of-care settings. The company's mission is to empower ophthalmology and neurology communities by providing accessible monitoring of eye and brain health, addressing the gap in frequent clinical visits and imaging exams for diseases like Multiple Sclerosis (MS) and Age-Related Macular Degeneration (AMD). JuneBrain is recognized as a women-owned small business and certified women's business enterprise.

JuneBrain Inc. develops telehealth Optical Coherence Tomography (OCT) devices and AI software to optimize the remote monitoring of neurological and retinal diseases. Their user-friendly, portable solutions aim to enhance research, streamline clinical trials, and broaden access to advanced care in clinical and point-of-care settings. The company's mission is to empower ophthalmology and neurology communities by providing accessible monitoring of eye and brain health, addressing the gap in frequent clinical visits and imaging exams for diseases like Multiple Sclerosis (MS) and Age-Related Macular Degeneration (AMD). JuneBrain is recognized as a women-owned small business and certified women's business enterprise.
Headquarters: Baltimore, Maryland
Founded: 2017
Core product: Portable/wearable OCT hardware (Neuro-i) plus AI image analysis
Focus: Remote/point-of-care retinal and neurological monitoring (e.g., MS, AMD)
Team size (approx.): 16 employees
Funding type: Grants and early-stage investors
Limited access to frequent clinical imaging and monitoring for neurological and retinal diseases; need for telehealth-capable imaging solutions for research and point-of-care settings.
2017
Biotechnology
Latest disclosed grant entry on Crunchbase
Recent grant/non-equity assistance
1000000 USD
NSF STTR award
“Mix of grant/non-dilutive funding (NSF, TEDCO, MDIC) plus participation from accelerators/early-stage investors (Halcyon Angels, MedTech Innovator, AlphaLab Health, 2Gether-International, Innovation Works)”